These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 11711314)
1. Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent. Ogawa M; Hatano K; Kawasumi Y; Wichmann J; Ito K Nucl Med Biol; 2001 Nov; 28(8):941-7. PubMed ID: 11711314 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo. Dautzenberg FM; Wichmann J; Higelin J; Py-Lang G; Kratzeisen C; Malherbe P; Kilpatrick GJ; Jenck F J Pharmacol Exp Ther; 2001 Aug; 298(2):812-9. PubMed ID: 11454946 [TBL] [Abstract][Full Text] [Related]
3. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. Chiou LC; Chuang KC; Wichmann J; Adam G J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties. Wichmann J; Adam G; Röver S; Hennig M; Scalone M; Cesura AM; Dautzenberg FM; Jenck F Eur J Med Chem; 2000 Sep; 35(9):839-51. PubMed ID: 11006485 [TBL] [Abstract][Full Text] [Related]
5. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue. Recker MD; Higgins GA J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383 [TBL] [Abstract][Full Text] [Related]
6. Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain. Gehlert DR; Gackenheimer SL; Shaw JL Neuropeptides; 2006 Apr; 40(2):95-105. PubMed ID: 16403422 [TBL] [Abstract][Full Text] [Related]
9. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Ciccocioppo R; Biondini M; Antonelli L; Wichmann J; Jenck F; Massi M Psychopharmacology (Berl); 2002 May; 161(2):113-9. PubMed ID: 11981590 [TBL] [Abstract][Full Text] [Related]
10. High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor. Röver S; Adam G; Cesura AM; Galley G; Jenck F; Monsma FJ; Wichmann J; Dautzenberg FM J Med Chem; 2000 Apr; 43(7):1329-38. PubMed ID: 10753470 [TBL] [Abstract][Full Text] [Related]
11. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Jenck F; Wichmann J; Dautzenberg FM; Moreau JL; Ouagazzal AM; Martin JR; Lundstrom K; Cesura AM; Poli SM; Roever S; Kolczewski S; Adam G; Kilpatrick G Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4938-43. PubMed ID: 10758169 [TBL] [Abstract][Full Text] [Related]
12. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography. Ogawa M; Hatano K; Kawasumi Y; Ishiwata K; Kawamura K; Ozaki S; Ito K Nucl Med Biol; 2003 Jan; 30(1):51-9. PubMed ID: 12493543 [TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of [123I]-8-[4-[2-(5-iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3 ,8-tri azaspiro[4.5]decan-4-one as a potential dopamine D2 receptor radioligand for SPECT. Waterhouse RN; Gotsick JT; Kabalka GW; Goodman MM; O'Brien JC Nucl Med Biol; 1998 Jan; 25(1):77-80. PubMed ID: 9466366 [No Abstract] [Full Text] [Related]
15. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. Kuzmin A; Sandin J; Terenius L; Ogren SO J Pharmacol Exp Ther; 2003 Jan; 304(1):310-8. PubMed ID: 12490606 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human. Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431 [TBL] [Abstract][Full Text] [Related]